Genomic testing, tumor microenvironment and targeted therapy of Hedgehog-related human cancers
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genomic testing, tumor microenvironment and targeted therapy of Hedgehog-related human cancers
Authors
Keywords
-
Journal
CLINICAL SCIENCE
Volume 133, Issue 8, Pages 953-970
Publisher
Portland Press Ltd.
Online
2019-04-30
DOI
10.1042/cs20180845
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- Effective anti-programmed death-1 therapy in a SUFU -mutated patient with Gorlin-Goltz syndrome
- (2018) A. Moreira et al. BRITISH JOURNAL OF DERMATOLOGY
- Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer
- (2018) Rona Yaeger et al. CANCER CELL
- Emerging trends in the treatment of advanced basal cell carcinoma
- (2018) Michael R. Migden et al. CANCER TREATMENT REVIEWS
- Structural Basis of Smoothened Activation in Hedgehog Signaling
- (2018) Pengxiang Huang et al. CELL
- Involvement of hedgehog pathway in early onset, aggressive molecular subtypes and metastatic potential of breast cancer
- (2018) Syeda Kiran Riaz et al. Cell Communication and Signaling
- GPCRs: Emerging anti-cancer drug targets
- (2018) Ainhoa Nieto Gutierrez et al. CELLULAR SIGNALLING
- Phase I Study of LY2940680, a Smo Antagonist, in Patients with Advanced Cancer Including Treatment-Naïve and Previously Treated Basal Cell Carcinoma
- (2018) Johanna Bendell et al. CLINICAL CANCER RESEARCH
- Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape
- (2018) Max D. Wellenstein et al. IMMUNITY
- Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study
- (2018) John D. Hainsworth et al. JOURNAL OF CLINICAL ONCOLOGY
- Hedgehog pathway mutations drive oncogenic transformation in high-risk T-cell acute lymphoblastic leukemia
- (2018) Melissa A. Burns et al. LEUKEMIA
- Hedgehog signaling contributes to bone cancer pain by regulating sensory neuron excitability in rats
- (2018) Su Liu et al. Molecular Pain
- Targeting GLI Transcription Factors in Cancer
- (2018) Miroslava Didiasova et al. MOLECULES
- Noncanonical hedgehog pathway activation through SRF–MKL1 promotes drug resistance in basal cell carcinomas
- (2018) Ramon J Whitson et al. NATURE MEDICINE
- Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
- (2018) Dai Fukumura et al. Nature Reviews Clinical Oncology
- PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma
- (2018) Michael R. Migden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Macrophage conditioned medium promotes colorectal cancer stem cell phenotype via the hedgehog signaling pathway
- (2018) Fan Fan et al. PLoS One
- Hypoxic tumor microenvironment activates GLI2 via HIF-1α and TGF-β2 to promote chemoresistance in colorectal cancer
- (2018) Yen-An Tang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype
- (2018) Sang Cheul Oh et al. Nature Communications
- Itch/β-arrestin2-dependent non-proteolytic ubiquitylation of SuFu controls Hedgehog signalling and medulloblastoma tumorigenesis
- (2018) Paola Infante et al. Nature Communications
- Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer
- (2018) Aurélie S. Cazet et al. Nature Communications
- Patched-2 functions to limit Patched-1 deficient skin cancer growth
- (2018) Veronique L. Veenstra et al. CELLULAR ONCOLOGY
- PD-L1 expression in medulloblastoma: an evaluation by subgroup
- (2018) Allison M. Martin et al. Oncotarget
- Anti-PD-1 Therapy Leads to Near-Complete Remission in a Patient with Metastatic Basal Cell Carcinoma
- (2018) Stefanie Fischer et al. Oncology Research and Treatment
- New mutations and an updated database for the patched-1 (PTCH1 ) gene
- (2018) Marie G. Reinders et al. Molecular Genetics & Genomic Medicine
- Glasdegib in combination with cytarabine and daunorubicin in patients with AML or high-risk MDS: Phase 2 study results
- (2018) Jorge E. Cortes et al. AMERICAN JOURNAL OF HEMATOLOGY
- Advanced Basal Cell Cancer: Concise Review of Molecular Characteristics and Novel Targeted and Immune Therapeutics
- (2018) M Nikanjam et al. ANNALS OF ONCOLOGY
- Epigenetic silencing of sonic hedgehog elicits antitumor immune response and suppresses tumor growth by inhibiting the hedgehog signaling pathway in metastatic spine tumors in Sprague-Dawley rats
- (2018) Guang Shi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Structures of human Patched and its complex with native palmitoylated sonic hedgehog
- (2018) Xiaofeng Qi et al. NATURE
- GLI1-expressing mesenchymal cells form the essential Wnt-secreting niche for colon stem cells
- (2018) Bahar Degirmenci et al. NATURE
- Activation of the Gi protein-RHOA axis by non-canonical Hedgehog signaling is independent of primary cilia
- (2018) Lan Ho Wei et al. PLoS One
- Reproducibility of academic preclinical translational research: lessons from the development of Hedgehog pathway inhibitors to treat cancer
- (2018) Tom Curran Open Biology
- Cilia-Associated Oxysterols Activate Smoothened
- (2018) David R. Raleigh et al. MOLECULAR CELL
- A cell identity switch allows residual BCC to survive Hedgehog pathway inhibition
- (2018) Brian Biehs et al. NATURE
- A slow-cycling LGR5 tumour population mediates basal cell carcinoma relapse after therapy
- (2018) Adriana Sánchez-Danés et al. NATURE
- Cancer immunoediting and resistance to T cell-based immunotherapy
- (2018) Jake S. O’Donnell et al. Nature Reviews Clinical Oncology
- Structural and Druggability Landscape of Frizzled G Protein-Coupled Receptors
- (2018) Xianjun Zhang et al. TRENDS IN BIOCHEMICAL SCIENCES
- Downregulation of ASPP2 promotes gallbladder cancer metastasis and macrophage recruitment via aPKC-ι/GLI1 pathway
- (2018) Li Tian et al. Cell Death & Disease
- Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial
- (2017) N. Basset-Séguin et al. EUROPEAN JOURNAL OF CANCER
- Pirfenidone exerts antifibrotic effects through inhibition of GLI transcription factors
- (2017) Miroslava Didiasova et al. FASEB JOURNAL
- Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4
- (2017) Paul J. Collins et al. FASEB JOURNAL
- Targeting class I histone deacetylases by the novel small molecule inhibitor 4SC-202 blocks oncogenic hedgehog-GLI signaling and overcomes smoothened inhibitor resistance
- (2017) Wolfgang Gruber et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular genetics and targeted therapy of WNT-related human diseases (Review)
- (2017) Masuko Katoh et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Understanding the Molecular Genetics of Basal Cell Carcinoma
- (2017) Cristina Pellegrini et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Collateral Damage Intended—Cancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy
- (2017) Ana Cavaco et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review)
- (2017) Masaru Katoh INTERNATIONAL JOURNAL OF ONCOLOGY
- Myeloid-derived suppressor cells: Important contributors to tumor progression and metastasis
- (2017) Elham Safarzadeh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Aberrant activation of hedgehog signaling promotes cell proliferation via the transcriptional activation of forkhead Box M1 in colorectal cancer cells
- (2017) DeJie Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT study
- (2017) J.T. Lear et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Gastroblastoma harbors a recurrent somatic MALAT1–GLI1 fusion gene
- (2017) Rondell P Graham et al. MODERN PATHOLOGY
- Cholesterol Modification of Smoothened Is Required for Hedgehog Signaling
- (2017) Xu Xiao et al. MOLECULAR CELL
- The whole-genome landscape of medulloblastoma subtypes
- (2017) Paul A. Northcott et al. NATURE
- CDK4/6 inhibition triggers anti-tumour immunity
- (2017) Shom Goel et al. NATURE
- Cyclin D–CDK4 kinase destabilizes PD-L1 via cullin 3–SPOP to control cancer immune surveillance
- (2017) Jinfang Zhang et al. NATURE
- Extra-mitochondrial prosurvival BCL-2 proteins regulate gene transcription by inhibiting the SUFU tumour suppressor
- (2017) Xiaofeng Wu et al. NATURE CELL BIOLOGY
- Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
- (2017) Ahmet Zehir et al. NATURE MEDICINE
- Monitoring immune-checkpoint blockade: response evaluation and biomarker development
- (2017) Mizuki Nishino et al. Nature Reviews Clinical Oncology
- Germline SUFU mutation carriers and medulloblastoma: clinical characteristics, cancer risk, and prognosis
- (2017) Léa Guerrini-Rousseau et al. NEURO-ONCOLOGY
- Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma
- (2017) Mark W Kieran et al. NEURO-ONCOLOGY
- Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma
- (2017) A Po et al. ONCOGENE
- A Transposon Screen Identifies Loss of Primary Cilia as a Mechanism of Resistance to SMO Inhibitors
- (2017) Xuesong Zhao et al. Cancer Discovery
- Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
- (2017) Pornpimol Charoentong et al. Cell Reports
- Association Between Programmed Death Ligand 1 Expression in Patients With Basal Cell Carcinomas and the Number of Treatment Modalities
- (2017) Julia Chang et al. JAMA Dermatology
- Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade
- (2017) Evan J. Lipson et al. Journal for ImmunoTherapy of Cancer
- Multi-layered mutation in hedgehog-related genes in Gorlin syndrome may affect the phenotype
- (2017) Shoko Onodera et al. PLoS One
- A Recurrent Mosaic Mutation in SMO , Encoding the Hedgehog Signal Transducer Smoothened, Is the Major Cause of Curry-Jones Syndrome
- (2016) Stephen R.F. Twigg et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Inhibition of Hedgehog signaling for the treatment of lymphoma and CLL: a phase II study from the LYSA: Table 1.
- (2016) R. Houot et al. ANNALS OF ONCOLOGY
- Segmental basal cell naevus syndrome caused by an activating mutation insmoothened
- (2016) Z. Khamaysi et al. BRITISH JOURNAL OF DERMATOLOGY
- CAT3, a novel agent for medulloblastoma and glioblastoma treatment, inhibits tumor growth by disrupting the Hedgehog signaling pathway
- (2016) Ju Chen et al. CANCER LETTERS
- Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-β pathways
- (2016) Jiao Liu et al. CANCER LETTERS
- Heterogeneous Stromal Signaling within the Tumor Microenvironment Controls the Metastasis of Pancreatic Cancer
- (2016) Agnieszka A. Rucki et al. CANCER RESEARCH
- Hedgehog Pathway Inhibition
- (2016) Aleksandar Sekulic et al. CELL
- Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
- (2016) Willy Hugo et al. CELL
- Individualized Molecular Analyses Guide Efforts (IMAGE): A Prospective Study of Molecular Profiling of Tissue and Blood in Metastatic Triple-Negative Breast Cancer
- (2016) Heather A. Parsons et al. CLINICAL CANCER RESEARCH
- Targeting regulatory T cells in tumors
- (2016) Chang Liu et al. FEBS Journal
- FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review)
- (2016) MASARU KATOH INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Hepatic expression of Sonic Hedgehog induces liver fibrosis and promotes hepatocarcinogenesis in a transgenic mouse model
- (2016) Sook In Chung et al. JOURNAL OF HEPATOLOGY
- RecurrentMALAT1-GLI1oncogenic fusion andGLI1up-regulation define a subset of plexiform fibromyxoma
- (2016) Lien Spans et al. JOURNAL OF PATHOLOGY
- MK-4101, a Potent Inhibitor of the Hedgehog Pathway, Is Highly Active against Medulloblastoma and Basal Cell Carcinoma
- (2016) Gessica Filocamo et al. MOLECULAR CANCER THERAPEUTICS
- Posaconazole, a Second-Generation Triazole Antifungal Drug, Inhibits the Hedgehog Signaling Pathway and Progression of Basal Cell Carcinoma
- (2016) B. Chen et al. MOLECULAR CANCER THERAPEUTICS
- Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma
- (2016) Ximena Bonilla et al. NATURE GENETICS
- Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma
- (2016) Mario E. Lacouture et al. ONCOLOGIST
- Endogenous B-ring oxysterols inhibit the Hedgehog component Smoothened in a manner distinct from cyclopamine or side-chain oxysterols
- (2016) Navdar Sever et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hypoxic control of metastasis
- (2016) E. B. Rankin et al. SCIENCE
- The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
- (2016) Vinit Kumar et al. TRENDS IN IMMUNOLOGY
- Therapeutics Targeting FGF Signaling Network in Human Diseases
- (2016) Masaru Katoh TRENDS IN PHARMACOLOGICAL SCIENCES
- Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemia
- (2016) David A. Irvine et al. Scientific Reports
- Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma
- (2016) Mina S. Ally et al. JAMA Dermatology
- Crosstalk between Wnt/β-catenin and Hedgehog/Gli signaling pathways in colon cancer and implications for therapy
- (2015) Li Song et al. CANCER BIOLOGY & THERAPY
- Smoothened Variants Explain the Majority of Drug Resistance in Basal Cell Carcinoma
- (2015) Scott X. Atwood et al. CANCER CELL
- Genomic Analysis of Smoothened Inhibitor Resistance in Basal Cell Carcinoma
- (2015) Hayley J. Sharpe et al. CANCER CELL
- Sonic hedgehog-glioma associated oncogene homolog 1 signaling enhances drug resistance in CD44+/Musashi-1+ gastric cancer stem cells
- (2015) Min Xu et al. CANCER LETTERS
- Differential Immune Microenvironments and Response to Immune Checkpoint Blockade among Molecular Subtypes of Murine Medulloblastoma
- (2015) C. D. Pham et al. CLINICAL CANCER RESEARCH
- Hedgehog Pathway Inhibitors Promote Adaptive Immune Responses in Basal Cell Carcinoma
- (2015) A. Otsuka et al. CLINICAL CANCER RESEARCH
- The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients
- (2015) Miao He et al. CLINICAL SCIENCE
- MRT-92 inhibits Hedgehog signaling by blocking overlapping binding sites in the transmembrane domain of the Smoothened receptor
- (2015) Lucile Hoch et al. FASEB JOURNAL
- Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer
- (2015) Daniel V.T. Catenacci et al. JOURNAL OF CLINICAL ONCOLOGY
- Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog–Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032
- (2015) Giles W. Robinson et al. JOURNAL OF CLINICAL ONCOLOGY
- GLI2 inhibition abrogates human leukemia stem cell dormancy
- (2015) Anil Sadarangani et al. Journal of Translational Medicine
- Efficacy of Hedgehog Pathway Inhibitors in Basal Cell Carcinoma
- (2015) N. Basset-Seguin et al. MOLECULAR CANCER THERAPEUTICS
- Regulation of the oncoprotein Smoothened by small molecules
- (2015) Hayley J Sharpe et al. Nature Chemical Biology
- A New Initiative on Precision Medicine
- (2015) Francis S. Collins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aberrant hedgehog signaling is responsible for the highly invasive behavior of a subpopulation of hepatoma cells
- (2015) Y-H Fan et al. ONCOGENE
- Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
- (2015) Agnieszka K. Witkiewicz et al. Nature Communications
- Sonic hedgehog inhibitors prevent colitis-associated cancer via orchestrated mechanisms of IL-6/gp130 inhibition, 15-PGDH induction, Bcl-2 abrogation, and tumorsphere inhibition
- (2015) Napapan Kangwan et al. Oncotarget
- Treatment with PF-04449913, an oral smoothened antagonist, in patients with myeloid malignancies: a phase 1 safety and pharmacokinetics study
- (2015) Giovanni Martinelli et al. Lancet Haematology
- Mode and specificity of binding of the small molecule GANT61 to GLI determines inhibition of GLI-DNA binding
- (2015) Akwasi Agyeman et al. Oncotarget
- Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition
- (2014) Marcel Kool et al. CANCER CELL
- A Phase I Study of PF-04449913, an Oral Hedgehog Inhibitor, in Patients with Advanced Solid Tumors
- (2014) A. J. Wagner et al. CLINICAL CANCER RESEARCH
- Phase I Dose-Escalation Trial of the Oral Investigational Hedgehog Signaling Pathway Inhibitor TAK-441 in Patients with Advanced Solid Tumors
- (2014) J. Goldman et al. CLINICAL CANCER RESEARCH
- A Phase I, Multicenter, Open-Label, First-in-Human, Dose-Escalation Study of the Oral Smoothened Inhibitor Sonidegib (LDE225) in Patients with Advanced Solid Tumors
- (2014) J. Rodon et al. CLINICAL CANCER RESEARCH
- Hedgehog-GLI Signaling Inhibition Suppresses Tumor Growth in Squamous Lung Cancer
- (2014) L. Huang et al. CLINICAL CANCER RESEARCH
- Gli1/DNA interaction is a druggable target for Hedgehog-dependent tumors
- (2014) P. Infante et al. EMBO JOURNAL
- Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
- (2014) Peter J. Murray et al. IMMUNITY
- Hedgehog signaling regulates FOXA2 in esophageal embryogenesis and Barrett’s metaplasia
- (2014) David H. Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- Open-Label, Exploratory Phase II Trial of Oral Itraconazole for the Treatment of Basal Cell Carcinoma
- (2014) Daniel J. Kim et al. JOURNAL OF CLINICAL ONCOLOGY
- Germline Mutations inSUFUCause Gorlin Syndrome–Associated Childhood Medulloblastoma and Redefine the Risk Associated WithPTCH1Mutations
- (2014) Miriam J. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Hedgehog pathway as a potential treatment target in human cholangiocarcinoma
- (2014) Dorothee Riedlinger et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Acquired resistance to TKIs in solid tumours: learning from lung cancer
- (2014) D. Ross Camidge et al. Nature Reviews Clinical Oncology
- Hedgehog acyltransferase as a target in pancreatic ductal adenocarcinoma
- (2014) E Petrova et al. ONCOGENE
- SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells
- (2014) R Santini et al. ONCOGENE
- Down-Regulation of Gli Transcription Factor Leads to the Inhibition of Migration and Invasion of Ovarian Cancer Cells via Integrin β4-Mediated FAK Signaling
- (2014) Qi Chen et al. PLoS One
- T-cell TGF- signaling abrogation restricts medulloblastoma progression
- (2014) D. Gate et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Context-dependent signal integration by the GLI code: The oncogenic load, pathways, modifiers and implications for cancer therapy
- (2014) Fritz Aberger et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Structural basis for Smoothened receptor modulation and chemoresistance to anticancer drugs
- (2014) Chong Wang et al. Nature Communications
- GDC-0449 in patients with advanced chondrosarcomas: a French Sarcoma Group/US and French National Cancer Institute Single-Arm Phase II Collaborative Study
- (2013) A. Italiano et al. ANNALS OF ONCOLOGY
- Trimeric G protein-CARMA1 axis links smoothened, the hedgehog receptor transducer, to NF- B activation in diffuse large B-cell lymphoma
- (2013) C. Qu et al. BLOOD
- Itraconazole and Arsenic Trioxide Inhibit Hedgehog Pathway Activation and Tumor Growth Associated with Acquired Resistance to Smoothened Antagonists
- (2013) James Kim et al. CANCER CELL
- Hypoxia Triggers Hedgehog-Mediated Tumor-Stromal Interactions in Pancreatic Cancer
- (2013) T. R. Spivak-Kroizman et al. CANCER RESEARCH
- Discovery of NVP-LEQ506, a Second-Generation Inhibitor of Smoothened
- (2013) Stefan Peukert et al. ChemMedChem
- Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors
- (2013) A. Jimeno et al. CLINICAL CANCER RESEARCH
- Combination of Ponatinib with Hedgehog Antagonist Vismodegib for Therapy-Resistant BCR-ABL1-Positive Leukemia
- (2013) S. Katagiri et al. CLINICAL CANCER RESEARCH
- Characterization of Distinct Immunophenotypes across Pediatric Brain Tumor Types
- (2013) A. M. Griesinger et al. JOURNAL OF IMMUNOLOGY
- Targeted STAT3 disruption in myeloid cells alters immunosuppressor cell abundance in a murine model of spontaneous medulloblastoma
- (2013) Catalina Abad et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Novel Neutralizing Hedgehog Antibody MEDI-5304 Exhibits Antitumor Activity by Inhibiting Paracrine Hedgehog Signaling
- (2013) N. R. Michaud et al. MOLECULAR CANCER THERAPEUTICS
- Structure of the human smoothened receptor bound to an antitumour agent
- (2013) Chong Wang et al. NATURE
- Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations
- (2013) Priscilla K Brastianos et al. NATURE GENETICS
- The mechanisms of Hedgehog signalling and its roles in development and disease
- (2013) James Briscoe et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Selective Identification of Hedgehog Pathway Antagonists By Direct Analysis of Smoothened Ciliary Translocation
- (2012) Yu Wang et al. ACS Chemical Biology
- Loss of SUFU Function in Familial Multiple Meningioma
- (2012) Mervi Aavikko et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Targeting hedgehog in hematologic malignancy
- (2012) D. A. Irvine et al. BLOOD
- The Crosstalk of mTOR/S6K1 and Hedgehog Pathways
- (2012) Yan Wang et al. CANCER CELL
- Abstract 5336: Macrophage migration inhibitory factor (MIF) plays roles in proliferation, survival and migration of Ewing tumor cells through the activation of several tyrosine kinases
- (2012) Hyung Gyoo Kang et al. CANCER RESEARCH
- A Phase II, Randomized, Placebo-Controlled Study of Vismodegib as Maintenance Therapy in Patients with Ovarian Cancer in Second or Third Complete Remission
- (2012) S. B. Kaye et al. CLINICAL CANCER RESEARCH
- A Randomized Phase II Trial of Vismodegib versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer
- (2012) J. Berlin et al. CLINICAL CANCER RESEARCH
- Inhibition of the Hedgehog Pathway Targets the Tumor-Associated Stroma in Pancreatic Cancer
- (2012) R. F. Hwang et al. MOLECULAR CANCER RESEARCH
- Subgroup-specific structural variation across 1,000 medulloblastoma genomes
- (2012) Paul A. Northcott et al. NATURE
- Sonic Hedgehog Pathway Promotes Metastasis and Lymphangiogenesis via Activation of Akt, EMT, and MMP-9 Pathway in Gastric Cancer
- (2011) Y. A. Yoo et al. CANCER RESEARCH
- Small Molecule Antagonists in Distinct Binding Modes Inhibit Drug-Resistant Mutant of Smoothened
- (2011) Haiyan Tao et al. CHEMISTRY & BIOLOGY
- Phase I Trial of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Refractory, Locally Advanced or Metastatic Solid Tumors
- (2011) P. M. LoRusso et al. CLINICAL CANCER RESEARCH
- In vitro and in vivo characterization of a novel hedgehog signaling antagonist in human glioblastoma cell lines
- (2011) Pietro Ferruzzi et al. INTERNATIONAL JOURNAL OF CANCER
- Effective Targeting of Hedgehog Signaling in a Medulloblastoma Model with PF-5274857, a Potent and Selective Smoothened Antagonist That Penetrates the Blood-Brain Barrier
- (2011) A. Rohner et al. MOLECULAR CANCER THERAPEUTICS
- Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
- (2011) Andrea Facciabene et al. NATURE
- Hedgehog Signaling Drives Cellular Survival in Human Colon Carcinoma Cells
- (2010) T. Mazumdar et al. CANCER RESEARCH
- Small Molecule Inhibition of GDC-0449 Refractory Smoothened Mutants and Downstream Mechanisms of Drug Resistance
- (2010) Gerrit J. P. Dijkgraaf et al. CANCER RESEARCH
- Hedgehog proteins activate pro-angiogenic responses in endothelial cells through non-canonical signaling pathways
- (2010) Pilar Chinchilla et al. CELL CYCLE
- Hedgehog controls neural stem cells through p53-independent regulation of Nanog
- (2010) Agnese Po et al. EMBO JOURNAL
- Interactions between Hedgehog proteins and their binding partners come into view
- (2010) P. A. Beachy et al. GENES & DEVELOPMENT
- Requirement of TGFβ Signaling for SMO-mediated Carcinogenesis
- (2010) Qipeng Fan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway
- (2010) Elspeth M. Beauchamp et al. JOURNAL OF CLINICAL INVESTIGATION
- Interfering with Resistance to Smoothened Antagonists by Inhibition of the PI3K Pathway in Medulloblastoma
- (2010) S. Buonamici et al. Science Translational Medicine
- Evaluating Smoothened as a G-protein-coupled receptor for Hedgehog signalling
- (2010) Katie L. Ayers et al. TRENDS IN CELL BIOLOGY
- Hedgehog Target Genes: Mechanisms of Carcinogenesis Induced by Aberrant Hedgehog Signaling Activation
- (2009) Y. Katoh et al. CURRENT MOLECULAR MEDICINE
- Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia
- (2009) Chen Zhao et al. NATURE
- Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449
- (2009) Charles M. Rudin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma
- (2009) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor B
- (2009) C. Porta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma
- (2009) R. L. Yauch et al. SCIENCE
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
- (2009) K. P. Olive et al. SCIENCE
- Sonic Hedgehog Promotes Desmoplasia in Pancreatic Cancer
- (2008) J. M. Bailey et al. CLINICAL CANCER RESEARCH
- Pattern formation in the vertebrate neural tube: a sonic hedgehog morphogen-regulated transcriptional network
- (2008) E. Dessaud et al. DEVELOPMENT
- FoxF1 and FoxL1 Link Hedgehog Signaling and the Control of Epithelial Proliferation in the Developing Stomach and Intestine
- (2008) Blair B. Madison et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A paracrine requirement for hedgehog signalling in cancer
- (2008) Robert L. Yauch et al. NATURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started